Stabilisation of pharmacologically active compounds in sustained release compositions
A pharmaceutical composition comprising as the active agent a peptide in association with embonic acid or ascorbic acid or a salt thereof, excluding ψ ψ1) ACTH in association with embonic acid or acorbic acid or a salt thereof and ψ2) a LHRH active compound in association with ascorbic acid or a salt thereof,ψ in a matrix of a polylactide, having a lactide / glycolide molar ratio of from 100:0 to 40:60, a Mw of from 10.000 to 200.000 and a polydispersity of from 1.7 to 3.0. ψψ
-
(2008/06/13)
More Articles about upstream products of 6640-22-8